Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-16

Clinical Trial Update: Optimal Dose of i.v Oxycodone for Postoperative Pain After Laparoscopic Colorectal Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the optimal intravenous oxycodone dose for postoperative pain after laparoscopic colorectal surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pain | Phase 3 | Status: WITHDRAWN